1. Home
  2. AEYE vs RNXT Comparison

AEYE vs RNXT Comparison

Compare AEYE & RNXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AudioEye Inc.

AEYE

AudioEye Inc.

N/A

Current Price

$12.32

Market Cap

86.2M

Sector

Technology

ML Signal

N/A

Logo RenovoRx Inc.

RNXT

RenovoRx Inc.

N/A

Current Price

$1.16

Market Cap

79.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
AEYE
RNXT
Founded
2005
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
86.2M
79.4M
IPO Year
2011
2021

Fundamental Metrics

Financial Performance
Metric
AEYE
RNXT
Price
$12.32
$1.16
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
4
Target Price
★ $17.33
$7.13
AVG Volume (30 Days)
337.9K
★ 360.8K
Earning Date
10-26-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 30.56
20.00
EPS
★ N/A
N/A
Revenue
★ $40,311,000.00
$1,123,000.00
Revenue This Year
$8.43
$244.84
Revenue Next Year
$10.19
$195.26
P/E Ratio
★ N/A
N/A
Revenue Growth
14.52
★ 2511.63
52 Week Low
$5.31
$0.70
52 Week High
$14.68
$2.59

Technical Indicators

Market Signals
Indicator
AEYE
RNXT
Relative Strength Index (RSI) 65.28 36.64
Support Level $6.03 $1.09
Resistance Level $14.68 $1.30
Average True Range (ATR) 1.20 0.12
MACD 0.30 -0.00
Stochastic Oscillator 70.62 36.72

Price Performance

Historical Comparison
AEYE
RNXT

About AEYE AudioEye Inc.

AudioEye Inc is a software solution provider delivering immediate ADA and WCAG accessibility compliance at scale. Through patented technology, subject matter expertise and proprietary processes, it is eradicating all barriers to digital accessibility, helping creators get accessible and supporting them with ongoing advisory and automated upkeep. It helps everyone identify and resolve issues of accessibility and enhance user experiences, automating digital accessibility for the widest audiences. It generates revenue through the sale of subscriptions for software-as-a-service (SaaS). accessibility solutions.

About RNXT RenovoRx Inc.

RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical needs with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed for targeted therapeutic delivery across the arterial wall near the tumor site (known as intra-arterial, or IA delivery) to bathe the target tumor, while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.

Share on Social Networks: